Regeneron Pharmaceuticals | أسهم رأس المال العادية



Ordinary Share Capital تغيير تاريخ
AbbVie USD 18M 0 2024-12
Agios Pharmaceuticals USD 58.04M 57.96M 2025-06
Alnylam Pharmaceuticals USD 130.98M 129.67M 2025-06
Amgen USD 538M 33.04B 2025-06
Astellas Pharma JPY 1.79B 101.21B 2025-06
AstraZeneca USD 1.55B 1.16B 2025-06
Biogen USD 146.6M 146.5M 2025-06
BioMarin Pharmaceutical USD 192M 191.81M 2025-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-06
Eli Lilly USD 946.83M 354.23M 2025-06
Gilead Sciences USD 1.24B 3M 2025-06
GlaxoSmithKline GBP 4.15B 2.8B 2025-06
Incyte USD 194.12M 193.93M 2025-06
Ionis Pharmaceuticals USD 159.2M 159.04M 2025-06
J&J USD 3.12B 0 2025-03
Kyowa Hakko Kirin JPY 523.49M 26.22B 2025-06
Merck USD 1.79B 0 2025-03
Moderna USD 389M 388.96M 2025-06
Neurocrine Biosciences USD 99M 0 2025-06
Novartis USD 793M 0 2024-12
Novartis USD 793M 0 2024-12
Pfizer USD 5.68B 5.2B 2025-06
Regeneron Pharmaceuticals USD 106.4M 106.4M 2025-06
Roche Holding CHF 107M 0 2024-06
Sanofi 1.25B 52.53M 2025-03
Sarepta Therapeutics USD 97.71M 97.7M 2025-06
Teva Pharmaceutical Industries USD 1.15B 1.09B 2025-06
Ultragenyx Pharmaceutical USD 96.35M 2.45M 2025-06
United Therapeutics USD 45.22M 44.42M 2025-06
Vertex Pharmaceuticals USD 256.3M 253.7M 2025-06


Regeneron Pharmaceuticals أسهم رأس المال العادية - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Aug 2025.